Lucy W. Farr

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Revance Therapeutics, Inc. of $287.5 million aggregate principal amount of its 1.75% convertible senior…

Davis Polk advised the joint book-running managers and representatives of the underwriters on an SEC-registered offering by Stanley Black & Decker, Inc. of $750 million aggregate…

Davis Polk advised the joint book-running managers and representatives of the initial purchasers on a Rule 144A offering by Integra LifeSciences Holdings Corporation of $575 million…

Davis Polk advised the lead manager, sole book-runner and representative of the several underwriters in connection with Bank of America Corporation’s $1.1 billion SEC-registered offering of…

Davis Polk advised the term loan agent and DIP Agent in connection with the restructuring of Sheridan Holding Company II, LLC and its affiliated debtors (collectively, “Sheridan II”). On…

Davis Polk advised an ad hoc group of secured noteholders and the DIP facility agent in connection with the restructuring of Cloud Peak Energy Inc. and certain of its affiliates and with…

Davis Polk advised the forward purchasers and the forward sellers in connection with the execution of forward sale agreements relating to an aggregate of 1,212,120 shares of New Jersey…

Davis Polk advised an ad hoc group of senior unsecured noteholders in connection with the chapter 11 cases of Legacy Reserves, Inc. and certain of its subsidiaries (collectively, “Legacy”)…

Davis Polk is advising TGLT S.A. in connection with a series of recapitalization transactions pursuant to an restructuring support agreement (the “RSA”) entered into between TGLT and an ad…

Davis Polk advised the joint bookrunners in connection with a primary offering by BR Properties S.A. of common shares for an aggregate amount of R$1.05 billion (approximately US$247.5…